Cargando…

Isotretinoin Oil-Based Capsule Formulation Optimization

The purpose of this study was to develop and optimize an isotretinoin oil-based capsule with specific dissolution pattern. A three-factor-constrained mixture design was used to prepare the systemic model formulations. The independent factors were the components of oil-based capsule including beeswax...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Pi-Ju, Huang, Chi-Te, Lee, Chen-Chou, Li, Chi-Lin, Huang, Yaw-Bin, Tsai, Yi-Hung, Wu, Pao-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771438/
https://www.ncbi.nlm.nih.gov/pubmed/24068886
http://dx.doi.org/10.1155/2013/856967
_version_ 1782284199045103616
author Tsai, Pi-Ju
Huang, Chi-Te
Lee, Chen-Chou
Li, Chi-Lin
Huang, Yaw-Bin
Tsai, Yi-Hung
Wu, Pao-Chu
author_facet Tsai, Pi-Ju
Huang, Chi-Te
Lee, Chen-Chou
Li, Chi-Lin
Huang, Yaw-Bin
Tsai, Yi-Hung
Wu, Pao-Chu
author_sort Tsai, Pi-Ju
collection PubMed
description The purpose of this study was to develop and optimize an isotretinoin oil-based capsule with specific dissolution pattern. A three-factor-constrained mixture design was used to prepare the systemic model formulations. The independent factors were the components of oil-based capsule including beeswax (X (1)), hydrogenated coconut oil (X (2)), and soybean oil (X (3)). The drug release percentages at 10, 30, 60, and 90 min were selected as responses. The effect of formulation factors including that on responses was inspected by using response surface methodology (RSM). Multiple-response optimization was performed to search for the appropriate formulation with specific release pattern. It was found that the interaction effect of these formulation factors (X (1) X (2), X (1) X (3), and X (2) X (3)) showed more potential influence than that of the main factors (X (1), X (2), and X (3)). An optimal predicted formulation with Y (10 min), Y (30 min), Y (60 min), and Y (90 min) release values of 12.3%, 36.7%, 73.6%, and 92.7% at X (1), X (2), and X (3) of 5.75, 15.37, and 78.88, respectively, was developed. The new formulation was prepared and performed by the dissolution test. The similarity factor f (2) was 54.8, indicating that the dissolution pattern of the new optimized formulation showed equivalence to the predicted profile.
format Online
Article
Text
id pubmed-3771438
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37714382013-09-25 Isotretinoin Oil-Based Capsule Formulation Optimization Tsai, Pi-Ju Huang, Chi-Te Lee, Chen-Chou Li, Chi-Lin Huang, Yaw-Bin Tsai, Yi-Hung Wu, Pao-Chu ScientificWorldJournal Research Article The purpose of this study was to develop and optimize an isotretinoin oil-based capsule with specific dissolution pattern. A three-factor-constrained mixture design was used to prepare the systemic model formulations. The independent factors were the components of oil-based capsule including beeswax (X (1)), hydrogenated coconut oil (X (2)), and soybean oil (X (3)). The drug release percentages at 10, 30, 60, and 90 min were selected as responses. The effect of formulation factors including that on responses was inspected by using response surface methodology (RSM). Multiple-response optimization was performed to search for the appropriate formulation with specific release pattern. It was found that the interaction effect of these formulation factors (X (1) X (2), X (1) X (3), and X (2) X (3)) showed more potential influence than that of the main factors (X (1), X (2), and X (3)). An optimal predicted formulation with Y (10 min), Y (30 min), Y (60 min), and Y (90 min) release values of 12.3%, 36.7%, 73.6%, and 92.7% at X (1), X (2), and X (3) of 5.75, 15.37, and 78.88, respectively, was developed. The new formulation was prepared and performed by the dissolution test. The similarity factor f (2) was 54.8, indicating that the dissolution pattern of the new optimized formulation showed equivalence to the predicted profile. Hindawi Publishing Corporation 2013-08-26 /pmc/articles/PMC3771438/ /pubmed/24068886 http://dx.doi.org/10.1155/2013/856967 Text en Copyright © 2013 Pi-Ju Tsai et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tsai, Pi-Ju
Huang, Chi-Te
Lee, Chen-Chou
Li, Chi-Lin
Huang, Yaw-Bin
Tsai, Yi-Hung
Wu, Pao-Chu
Isotretinoin Oil-Based Capsule Formulation Optimization
title Isotretinoin Oil-Based Capsule Formulation Optimization
title_full Isotretinoin Oil-Based Capsule Formulation Optimization
title_fullStr Isotretinoin Oil-Based Capsule Formulation Optimization
title_full_unstemmed Isotretinoin Oil-Based Capsule Formulation Optimization
title_short Isotretinoin Oil-Based Capsule Formulation Optimization
title_sort isotretinoin oil-based capsule formulation optimization
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771438/
https://www.ncbi.nlm.nih.gov/pubmed/24068886
http://dx.doi.org/10.1155/2013/856967
work_keys_str_mv AT tsaipiju isotretinoinoilbasedcapsuleformulationoptimization
AT huangchite isotretinoinoilbasedcapsuleformulationoptimization
AT leechenchou isotretinoinoilbasedcapsuleformulationoptimization
AT lichilin isotretinoinoilbasedcapsuleformulationoptimization
AT huangyawbin isotretinoinoilbasedcapsuleformulationoptimization
AT tsaiyihung isotretinoinoilbasedcapsuleformulationoptimization
AT wupaochu isotretinoinoilbasedcapsuleformulationoptimization